Short answer
Beauty Health Co (SKIN) filed an 8-K current report with the SEC on August 6, 2026 reporting Item 2.02 (Results of Operations and Financial Condition), Item EX-99.1 (Exhibit EX-99.1). FY2026 results disclosure includes non-GAAP financial measures.
Beauty Health Co 8-K event analysis
AI summary of each reported item and its exhibits
Item 2.02 · Results of Operations and Financial Condition
- FY2026 results disclosure includes non-GAAP financial measures
- GAAP-to-non-GAAP reconciliation available in Exhibit 99.1 press release
- Management used press release and conference call channels for investor disclosure
- Investors should review Exhibit 99.1 for the underlying financial results and adjustments
Item EX-99.1 · Exhibit EX-99.1
- Q2 net sales fell 7.8% to $72.1M, with delivery-system sales down to $18.3M and systems sold declining to 770
- Gross margin rose to 68.4% and adjusted EBITDA increased to $17.0M, despite lower revenue, reflecting cost discipline
- Net loss was $2.7M versus $19.7M prior-year income, which benefited from an $18.1M notes-related gain
- Fiscal 2026 guidance reduced to $280–$290M revenue and $39–$46M adjusted EBITDA, signaling continued demand pressure
- Cash declined to $206.1M, while October 2026 maturity of 1.25% convertible notes creates a near-term refinancing or repayment risk
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other Beauty Health Co 8-K filings
Get the next SKIN 8-K as it lands
Follow SKIN for push alerts, or ask the research agent what this filing means.